Press Releases

Powder containment and sterile transfer solutions experts, ChargePoint Technology, announced that it has entered into a collaboration with STERIS, a leading provider of infection prevention and other procedural products and services, to offer a unique and integrated solution for...

Biocon Ltd., an innovation-led global biopharmaceuticals company, announced that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb®) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome...

Providing air cargo service to 127 countries worldwide, Turkish Cargo’s “CARGY”, the new artificial intelligence robot that provides customers with the opportunity to inquire the status of their cargo 24/7, goes live. During its initial phase, Cargy, the artificial intelligence-based...

Allergan, an AbbVie company, announced that the U.S. FDA approved a supplemental Biologics License Application (sBLA) that supports expanded use of BOTOX® for the treatment of spasticity in pediatric patients 2 years of age and older, including those with...

Life science and data technology innovator, Aigenpulse,is introducing a new state of-the-art data intelligence platform which is designed to expedite the drug discovery and development process. The Aigenpulse platform harnesses the latest artificial intelligence and machine learning tools to...

With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions. Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) is further...

AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) has been approved in the EU for patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer. Pancreatic cancer is a rare, life-threatening disease with the lowest survival rate among the...